Tumor News and Research

RSS

Study identifies substance released by pancreatic cancer cells to disarm attacking macrophages

A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute identifies a substance released by pancreatic cancer cells that protect them from attack by immune cells called macrophages.

21 Nov 2017

UVA scientists working to find end-around method to stop triple-negative breast cancer

So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

20 Nov 2017

Researcher awarded $1.5 million to study role of tumor necrosis factor in IBD

D. Brent Polk, MD, AGAF, an investigator at Children's Hospital Los Angeles, has been awarded $1.5 million by the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH for the study of tumor necrosis factor (TNF) and its role in inflammatory bowel disease (IBD).

20 Nov 2017

Over-the-counter decongestant found to be effective inhibitor of tumor stroma

CANCER researchers seeking non-toxic alternatives to harmful chemotherapy are reporting a highly significant result for a humble cold remedy.

20 Nov 2017

New technique holds promise to screen cancer cells for drug susceptibility

Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to months of treatment with a drug that isn't working.

20 Nov 2017

Cancer drugs may offer new way to control high blood pressure

Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.

20 Nov 2017

Researchers develop new tool to share clinico-genomic data

Researchers from Universidad Politécnica de Madrid have developed a new tool that provides standard and shared clinico-genomic data among European healthcare institutions.

20 Nov 2017

Study shows how naïve T-cells may affect tumor immunity and immunotherapy

The immune cells that are trained to fight off the body's invaders can become defective. It's what allows cancer to develop. So most research has targeted these co-called effector T-cells.

17 Nov 2017

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

Researchers at the Icahn School of Medicine at Mount Sinai have identified a protein that can be targeted to suppress growth of a common type of breast cancer known as "estrogen receptor positive" (ER+), including ER+ cancers that are resistant to standard treatments.

17 Nov 2017

Researchers find way to switch tumor cells between 2D and 3D morphology

Paving the way for testing experimental drugs in more realistic environments, scientists at the National Institute of Standards and Technology have discovered how to make tiny colonies of cells grow in useful new ways inside petri dishes.

17 Nov 2017

Groundbreaking study identifies protein as potential factor in cancer metastasis

U of G scientists have made a discovery that could reduce the spread of cancer by hindering a protein that binds cancer cells together and allows them to invade tissues.

17 Nov 2017

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

The U.S. Food and Drug Administration today approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of kidney cancer (renal cell carcinoma) returning after a kidney has been removed (nephrectomy).

17 Nov 2017

Breakthrough research brings new procedure closer to helping patients with blood cancer

A new procedure that can prevent the potentially lethal side effects of stem cell transplants is a step closer to helping more patients with blood cancers after a breakthrough in understanding of the key mechanism that makes it work.

17 Nov 2017

NYU Langone launches new, comprehensive center for facial paralysis

Thousands of New Yorkers every year will suffer some form of facial paralysis, a diagnosis with many causes which can greatly affect a person's appearance and day-to-day functioning.

16 Nov 2017

Genetic diversity of tumor tissues can be barrier to precision medicine in gastric and esophageal cancers

A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help physicians make better treatment choices for patients with gastric and esophageal adenocarcinoma.

15 Nov 2017

Scientists find key that allows neural differentiation of microRNA-deficient pluripotent stem cells

The more than 200 different types of human cells have the same DNA but express different ensembles of genes. Each cell type was derived from embryonic stem cells, which are called pluripotent stem cells because they can differentiate to all those different cell fates.

15 Nov 2017

Changes in multiple different genes drive world's most deadly forms of lung cancer

A new UC San Francisco–led study challenges the dogma in oncology that most cancers are caused by one dominant "driver" mutation that can be treated in isolation with a single targeted drug. Instead, the new research finds one of the world's most deadly forms of lung cancer is driven by changes in multiple different genes, which appear to work together to drive cancer progression and to allow tumors to evade targeted therapy.

15 Nov 2017

Synthetic double-stranded RNA may have potential for use as vaccine to prevent liver cancer

Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective treatments or drugs.

14 Nov 2017

Study provides new insights into basis for responsiveness of testicular cancer to chemotherapy

Cornell researchers have taken a major step toward answering a key question in cancer research: Why is testicular cancer so responsive to chemotherapy, even after it metastasizes?

14 Nov 2017

CHLA receives more than $1 million from St. Baldrick's Foundation for cancer research

Three physician-researchers with the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles have been awarded more than $1 million in grants from the St. Baldrick's Foundation, the largest private funder of childhood cancer research.

14 Nov 2017

Tumor News and Research

Study identifies substance released by pancreatic cancer cells to disarm attacking macrophages

UVA scientists working to find end-around method to stop triple-negative breast cancer

Researcher awarded $1.5 million to study role of tumor necrosis factor in IBD

Over-the-counter decongestant found to be effective inhibitor of tumor stroma

New technique holds promise to screen cancer cells for drug susceptibility

Cancer drugs may offer new way to control high blood pressure

Researchers develop new tool to share clinico-genomic data

Study shows how naïve T-cells may affect tumor immunity and immunotherapy

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

Researchers find way to switch tumor cells between 2D and 3D morphology

Groundbreaking study identifies protein as potential factor in cancer metastasis

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

Breakthrough research brings new procedure closer to helping patients with blood cancer

NYU Langone launches new, comprehensive center for facial paralysis

Genetic diversity of tumor tissues can be barrier to precision medicine in gastric and esophageal cancers

Scientists find key that allows neural differentiation of microRNA-deficient pluripotent stem cells

Changes in multiple different genes drive world's most deadly forms of lung cancer

Synthetic double-stranded RNA may have potential for use as vaccine to prevent liver cancer

Study provides new insights into basis for responsiveness of testicular cancer to chemotherapy

CHLA receives more than $1 million from St. Baldrick's Foundation for cancer research

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News